Gilles A. Salles - Articles and news items

Gilead logo
Gilead logo

Gilead announces interim Phase 2 data for Idelalisib

Industry news, News / 17 June 2013 / Gilead Sciences, Inc.

Gilead Sciences announced interim results from a single-arm, open-label Phase 2 study evaluating idelalisib…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+